3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Hematologic Diseases
1
Bone Marrow Diseases
1
Interventions
Drug Therapy
107
Cisplatin
98
Radiotherapy
89
Carboplatin
86
Bevacizumab
79
Oxaliplatin
74
Capecitabine
69
tislelizumab
68
Gemcitabine
64
Cyclophosphamide
64
toripalimab
62
Paclitaxel
58
pembrolizumab
56
Specimen Handling
54
sintilimab
53
Surgical Procedures, Operative
52
anlotinib
51
Magnetic Resonance Spectroscopy
50
Fluorouracil
49
Immune Checkpoint Inhibitors
43
Blood Specimen Collection
42
130-nm albumin-bound paclitaxel
42
Standard of Care
38
camrelizumab
36
fludarabine
35
Leucovorin
34
lenvatinib
33
venetoclax
30
Radiosurgery
30
Immunotherapy
30
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
OTHER
×
Bone Marrow Examination
×
Clear all
NCT07387354
2026-03-16
MDS
Thomas Jefferson University
Phase 1/2
Not yet recruiting
25 enrolled